Skip to main content
. 2004 Jul;88(7):877–883. doi: 10.1136/bjo.2003.029330

Table 1.

 Demographic data (intent to treat population)

Fixed combination latanoprost/timolol (n = 163) Unfixed combination brimonidine/timolol (n = 162)
Sex, n (%)
    Male 73 (44.8) 73 (45.1)
    Female 90 (55.2) 89 (54.9)
Age (years)
    Mean 65.5 65.1
    SD 10.30 11.56
    Range 33–91 23–87
Ethnic origin, n (%)
    White 158 (96.9) 160 (98.8)
    Black 0 (0.0) 1 (0.6)
    Hispanic 4 (2.5) 1 (0.6)
    Other 1 (0.6) 0 (0.0)
Eye colour of study eye(s), n (%)
    Homogeneously blue, grey or green 48 (29.4) 48 (29.6)
    Homogeneously brown 85 (52.1) 88 (54.3)
    Blue-brown/grey-brown 19 (11.7) 14 (8.6)
    Green-brown 8 (4.9) 6 (3.7)
    Yellow-brown 3 (1.8) 6 (3.7)
Study eye(s), n (%)
    Right 41 (25.2) 34 (21.0)
    Left 33 (20.2) 31 (19.1)
    Both 89 (54.6) 97 (59.9)
Treated eye(s), n (%)
    Right 27 (16.6) 26 (16.0)
    Left 37 (22.7) 30 (18.5)
    Both 99 (60.7) 106 (65.4)
Diagnosis of study eye(s), n (%)
    Primary open angle glaucoma 119 (73.0) 111 (68.5)
    Ocular hypertension 37 (22.7) 43 (26.5)
    Other specifications 4 (2.5) 7 (4.3)
    Mixed* 3 (1.8) 1 (0.6)
Duration of condition (study eye)
    <6 months 11 (6.7) 6 (3.7)
    6 to<36 months 51 (31.3) 51 (31.5)
    36 to<120 months 78 (47.9) 75 (46.3)
    ⩾120 months 23 (14.1) 30 (18.5)

*Different diagnosis in right and left eyes.

SD, standard deviation.